Levetiracetam 1a Pharma (Levetiracetam)

Levetiracetam binds to the synaptic vesicle protein SV2A in the brain, which modulates neurotransmitter release. By stabilizing neuronal firing and decreasing abnormal excitability, it helps prevent the rapid, uncontrolled electrical activity that leads to seizures.

The appropriate dose of Levetiracetam 1a Pharma is determined by the prescribing clinician based on the patient’s age, weight, renal function and seizure type. Dosage adjustments are individualized, and patients should follow the specific instructions provided by their healthcare provider.

Safety data for levetiracetam in pregnancy and lactation are limited. The medication should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their doctor.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Levetiracetam differs from many traditional antiepileptics because it has a unique mechanism targeting SV2A and does not significantly affect hepatic enzymes. This results in fewer drug‑drug interactions compared with agents like carbamazepine or phenytoin, though dose adjustments may still be needed in renal impairment.

Levetiracetam 1a Pharma should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture and direct sunlight to maintain stability and potency throughout its shelf life.

Levetiracetam is taken orally, usually as a tablet. It can be swallowed whole with water, and may be taken with or without food. The exact dosing schedule—once, twice or three times daily—depends on the prescriber’s instructions.

Serious risks include severe skin reactions such as Stevens‑Johnson syndrome, mood changes like depression or suicidal thoughts, and rare blood disorders. Patients should seek immediate medical attention if they notice rash, mood swings, or signs of infection.

Levetiracetam is contraindicated in individuals with known hypersensitivity to the drug or any of its components. Caution is advised for patients with severe renal impairment, active psychiatric disorders, or those who are pregnant without a clear medical justification.